SL Science Holding Ltd（SLBT）股票分析

$1.230

+0.086 (+6.96%)收盤時

Loading chart…

最高: 1.470
開盤: 1.150
成交量加權均價: 1.24
成交量: 52.46K
市值: —
最低: 1.020
成交金額: 65.05K
企業價值/稅息折舊攤銷前利潤（TTM）: 0.00

SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (γδ) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.

www.slbtgroup.com

AI 分析 of SL Science Holding Ltd (SLBT)

賣出

SL Science Holding Ltd is not a good buy right now due to significant financial instability and poor performance metrics. The current price is $1.15, with a staggering year-to-date change of -80.17%. Additionally, the company has a current ratio of 0.00, indicating severe liquidity issues, and a negative net income of -29,122 USD in the latest quarter, which raises concerns about its operational viability.